Company Profile

Acetaminophen Toxicity Diagnostics LLC
Profile last edited on: 11/21/2019      CAGE: 4KZR9      UEI: M7PNUQVP4RE3

Business Identifier: Rapid point-of-care diagnostic test for (APAP) Acetaminophen poisoning
Year Founded
2006
First Award
2008
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

800 Marshall Street
Little Rock, AR 72202
   (501) 364-1418
   jameslaurap@uams.edu
   N/A
Location: Single
Congr. District: 02
County: Pulask

Public Profile

Anchored in research done at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children's Hospital, Acetaminophen Toxicity Diagnostics (ATD) is developing a rapid point-of-care diagnostic dipstick test for detecting acetaminophen poisoning in patients. Excessive doses of acetaminophen,- main ingredient in Tylenol-containing products - are the leading cause of acute liver failure in the U.S. TATD has been developing a commercial dipstick test that within 20 minutes can diagnose acetaminophen-induced liver injury. This is insharp contrast to current tests typically requiring 1-2 days post admission. . Further, ATD’s test can provide positive results for up to 7 days following acetaminophen overdose, so that a greater number of patients who have overdosed on acetaminophen can be accurately diagnosed and receive treatment to reduce the potential extent of liver damage.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $4,149,856
Project Title: Dipstick Assay for Detection of Acetaminophen Protein Adducts

Key People / Management

  Jack Hinson -- Co-Founder

  Laura P James -- Chief Medical Officer Co-Founder

  Dean Roberts -- Co-Founder